Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

In Memoriam: John A. Hansen (1943-2019).

Martin PJ, Petersdorf EW.

HLA. 2019 Sep 10. doi: 10.1111/tan.13674. [Epub ahead of print] No abstract available.

PMID:
31507090
2.

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation.

Fatobene G, Storer BE, Salit RB, Lee SJ, Martin PJ, Cheng GS, Carpenter PA, Balgansuren G, Petersdorf EW, Delaney C, Sandmaier BM, Milano F, Flowers ME.

Haematologica. 2019 Apr;104(4):835-843. doi: 10.3324/haematol.2018.202754. Epub 2018 Nov 15.

3.

The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

Petersdorf EW, O'hUigin C.

Hum Immunol. 2019 Jan;80(1):67-78. doi: 10.1016/j.humimm.2018.10.002. Epub 2018 Oct 12. Review.

PMID:
30321633
4.

Patient HLA Germline Variation and Transplant Survivorship.

Petersdorf EW, Stevenson P, Malkki M, Strong RK, Spellman SR, Haagenson MD, Horowitz MM, Gooley T, Wang T.

J Clin Oncol. 2018 Aug 20;36(24):2524-2531. doi: 10.1200/JCO.2017.77.6534. Epub 2018 Jun 14.

5.

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ.

Biol Blood Marrow Transplant. 2018 May;24(5):1049-1056. doi: 10.1016/j.bbmt.2018.02.006. Epub 2018 Feb 14.

6.

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility.

Eaton KD, Romine PE, Goodman GE, Thornquist MD, Barnett MJ, Petersdorf EW.

J Thorac Oncol. 2018 May;13(5):649-659. doi: 10.1016/j.jtho.2018.01.022. Epub 2018 Mar 23.

7.

Which factors influence the development of GVHD in HLA-matched or mismatched transplants?

Petersdorf EW.

Best Pract Res Clin Haematol. 2017 Dec;30(4):333-335. doi: 10.1016/j.beha.2017.09.003. Epub 2017 Sep 22. Review.

8.

Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.

Schöne B, Bergmann S, Lang K, Wagner I, Schmidt AH, Petersdorf EW, Lange V.

Hum Immunol. 2018 Jan;79(1):20-27. doi: 10.1016/j.humimm.2017.11.001. Epub 2017 Nov 7.

9.

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

Samuelson Bannow BT, Salit RB, Storer BE, Stevens EA, Wu D, Yeung C, Fang M, Petersdorf EW, Linenberger ML, Woo J, Sorror ML, Doney K, Sandmaier BM, Deeg HJ, Scott BL.

Biol Blood Marrow Transplant. 2018 Feb;24(2):386-392. doi: 10.1016/j.bbmt.2017.09.016. Epub 2017 Sep 29.

10.

Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.

Petersdorf EW.

F1000Res. 2017 May 3;6:617. doi: 10.12688/f1000research.10990.1. eCollection 2017. Review.

11.

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

Boudreau JE, Giglio F, Gooley TA, Stevenson PA, Le Luduec JB, Shaffer BC, Rajalingam R, Hou L, Hurley CK, Noreen H, Reed EF, Yu N, Vierra-Green C, Haagenson M, Malkki M, Petersdorf EW, Spellman S, Hsu KC.

J Clin Oncol. 2017 Jul 10;35(20):2268-2278. doi: 10.1200/JCO.2016.70.7059. Epub 2017 May 18.

12.

In celebration of Ruggero Ceppellini: HLA in transplantation.

Petersdorf EW.

HLA. 2017 Feb;89(2):71-76. doi: 10.1111/tan.12955. Review.

13.

Mismatched unrelated donor transplantation.

Petersdorf EW.

Semin Hematol. 2016 Oct;53(4):230-236. doi: 10.1053/j.seminhematol.2016.07.003. Epub 2016 Jul 25. Review.

14.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

Shaw BE, Hahn T, Martin PJ, Mitchell SA, Petersdorf EW, Armstrong GT, Shelburne N, Storer BE, Bhatia S.

Biol Blood Marrow Transplant. 2017 Jan;23(1):10-23. doi: 10.1016/j.bbmt.2016.08.018. Epub 2016 Aug 30. Review.

15.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

Brunstein CG, Petersdorf EW, DeFor TE, Noreen H, Maurer D, MacMillan ML, Ustun C, Verneris MR, Miller JS, Blazar BR, McGlave PB, Weisdorf DJ, Wagner JE.

Biol Blood Marrow Transplant. 2016 Mar;22(3):487-92. doi: 10.1016/j.bbmt.2015.09.025. Epub 2015 Sep 30.

16.

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.

Deeg HJ, Bredeson C, Farnia S, Ballen K, Gupta V, Mesa RA, Popat U, Hari P, Saber W, Seftel M, Tamari R, Petersdorf EW.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1883-7. doi: 10.1016/j.bbmt.2015.09.005. Epub 2015 Sep 11. Review.

17.

High HLA-DP Expression and Graft-versus-Host Disease.

Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P.

N Engl J Med. 2015 Aug 13;373(7):599-609. doi: 10.1056/NEJMoa1500140.

18.

A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.

Hardikar S, Johnson LG, Malkki M, Petersdorf EW, Galloway DA, Schwartz SM, Madeleine MM.

Gynecol Oncol. 2015 Oct;139(1):90-6. doi: 10.1016/j.ygyno.2015.07.110. Epub 2015 Aug 1.

19.

HLA mismatching in transplantation.

Petersdorf EW.

Blood. 2015 Feb 12;125(7):1058-9. doi: 10.1182/blood-2014-12-619015. No abstract available.

PMID:
25678436
20.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

Arora M, Hemmer MT, Ahn KW, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y, Weisdorf DJ, Li P, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola LM, Jacobsohn DA, Jagasia M, Klumpp TR, Petersdorf EW, Santarone S, Schouten HC, Wingard JR, Spellman SR, Pavletic SZ, Lee SJ, Horowitz MM, Flowers ME.

Biol Blood Marrow Transplant. 2015 Apr;21(4):640-5. doi: 10.1016/j.bbmt.2014.10.022. Epub 2014 Dec 18.

21.

Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression.

Israeli M, Roelen DL, Carrington M, Petersdorf EW, Claas FH, Haasnoot GW, Oudshoorn M.

Front Immunol. 2014 Oct 27;5:547. doi: 10.3389/fimmu.2014.00547. eCollection 2014.

22.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.

Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn JY, Cairo MS, Cutler CS, Flowers ME, Gale RP, Herzig R, Isola LM, Jacobsohn DA, Jagasia MH, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Spellman SR, Schouten HC, Verdonck LF, Wingard JR, Weisdorf DJ, Horowitz MM, Pavletic SZ.

Clin Cancer Res. 2015 May 1;21(9):2020-8. doi: 10.1158/1078-0432.CCR-14-0586. Epub 2014 Oct 27.

23.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T, Haagenson MD, Horowitz MM, Hsu K, Jindra P, Madrigal A, Oudshoorn M, Ringdén O, Schroeder ML, Spellman SR, Tiercy JM, Velardi A, Witt CS, O'Huigin C, Apps R, Carrington M; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Blood. 2014 Dec 18;124(26):3996-4003. doi: 10.1182/blood-2014-09-599969. Epub 2014 Oct 16.

24.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C.

Blood. 2014 Oct 16;124(16):2596-606. doi: 10.1182/blood-2014-05-576041. Epub 2014 Aug 26.

25.

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

Fernandez-Viña MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, Battiwalla M, Baxter-Lowe LA, Gajewski J, Jakubowski AA, Marino S, Oudshoorn M, Marsh SG, Petersdorf EW, Schultz K, Turner EV, Waller EK, Woolfrey A, Umejiego J, Spellman SR, Setterholm M.

Blood. 2014 Feb 20;123(8):1270-8. doi: 10.1182/blood-2013-10-532671. Epub 2014 Jan 9.

26.

Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.

Bodelon C, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.

Int J Mol Epidemiol Genet. 2013 Nov 28;4(4):218-27. eCollection 2013.

27.

Comparison of statistics in association tests of genetic markers for survival outcomes.

Mendolia F, Klein JP, Petersdorf EW, Malkki M, Wang T.

Stat Med. 2014 Feb 28;33(5):828-44. doi: 10.1002/sim.5982. Epub 2013 Sep 18.

28.

The major histocompatibility complex: a model for understanding graft-versus-host disease.

Petersdorf EW.

Blood. 2013 Sep 12;122(11):1863-72. doi: 10.1182/blood-2013-05-355982. Epub 2013 Jul 22. Review.

29.

Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Galloway DA, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2014 Jan 15;134(2):437-44. doi: 10.1002/ijc.28364. Epub 2013 Aug 5.

30.

Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.

Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1197-203. doi: 10.1016/j.bbmt.2013.05.020. Epub 2013 Jun 6.

31.

Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.

Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.

BMC Cancer. 2013 May 1;13:219. doi: 10.1186/1471-2407-13-219.

32.

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Fernández-Viña MA, Klein JP, Haagenson M, Spellman SR, Anasetti C, Noreen H, Baxter-Lowe LA, Cano P, Flomenberg N, Confer DL, Horowitz MM, Oudshoorn M, Petersdorf EW, Setterholm M, Champlin R, Lee SJ, de Lima M.

Blood. 2013 May 30;121(22):4603-10. doi: 10.1182/blood-2013-02-481945. Epub 2013 Apr 17.

33.

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

Inamoto Y, Storer BE, Petersdorf EW, Nelson JL, Lee SJ, Carpenter PA, Sandmaier BM, Hansen JA, Martin PJ, Flowers ME.

Blood. 2013 Jun 20;121(25):5098-103. doi: 10.1182/blood-2012-10-464198. Epub 2013 Apr 1.

34.

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.

Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T.

Blood. 2013 Mar 7;121(10):1896-905. doi: 10.1182/blood-2012-11-465161. Epub 2013 Jan 10.

35.

Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2013 Jul;133(1):201-13. doi: 10.1002/ijc.28000. Epub 2013 Feb 12.

36.

16th IHIW: international histocompatibility working group in hematopoietic cell transplantation.

Petersdorf EW, Malkki M, Hsu K, Bardy P, Cesbron A, Dickinson A, Dubois V, Fleischhauer K, Kawase T, Madrigal A, Morishima Y, Shaw B, Spellman S, Spierings E, Stern M, Tiercy JM, Velardi A, Gooley T; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Int J Immunogenet. 2013 Feb;40(1):2-10. doi: 10.1111/iji.12022. Epub 2012 Dec 28.

37.

Identification of the MICA*070 allele by sequencing and phasing.

Moran D, Morishima S, Malkki M, Petersdorf EW.

Hum Immunol. 2013 May;74(5):557-61. doi: 10.1016/j.humimm.2012.11.009. Epub 2012 Nov 29.

38.

Genetics of graft-versus-host disease: the major histocompatibility complex.

Petersdorf EW.

Blood Rev. 2013 Jan;27(1):1-12. doi: 10.1016/j.blre.2012.10.001. Epub 2012 Nov 20. Review.

39.

MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.

Petersdorf EW, Malkki M, Gooley TA, Spellman SR, Haagenson MD, Horowitz MM, Wang T.

Sci Transl Med. 2012 Jul 25;4(144):144ra101. doi: 10.1126/scitranslmed.3003974.

40.

Genotyping of single nucleotide polymorphisms by 5' nuclease allelic discrimination.

Malkki M, Petersdorf EW.

Methods Mol Biol. 2012;882:173-82. doi: 10.1007/978-1-61779-842-9_10.

41.

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Lancet Oncol. 2012 Apr;13(4):366-74. doi: 10.1016/S1470-2045(12)70004-9. Epub 2012 Feb 15. Erratum in: Lancet Oncol. 2012 Apr;13(4):e134-5.

42.

Of genes, blocks, and haplotypes.

Petersdorf EW.

Biol Blood Marrow Transplant. 2012 Apr;18(4):494-6. doi: 10.1016/j.bbmt.2012.01.016. Epub 2012 Jan 30. No abstract available.

43.

Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia.

Pearce KF, Lee SJ, Haagenson M, Petersdorf EW, Norden J, Collin MP, Klein JP, Spellman SR, Lowerson SA, Davies S, Dickinson AM.

Haematologica. 2012 Jul;97(7):1014-9. doi: 10.3324/haematol.2011.053611. Epub 2012 Jan 22.

44.

Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Malkki M, Petersdorf EW, Schwartz SM.

Gynecol Oncol. 2012 Mar;124(3):525-8. doi: 10.1016/j.ygyno.2011.11.017. Epub 2011 Nov 28.

45.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ.

Blood. 2011 Oct 20;118(16):4472-9. doi: 10.1182/blood-2011-04-349068. Epub 2011 Aug 30.

46.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ.

Biol Blood Marrow Transplant. 2012 Feb;18(2):280-8. doi: 10.1016/j.bbmt.2011.07.024. Epub 2011 Jul 31.

47.

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.

Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW, McKnight B, Malone KE.

Breast Cancer Res Treat. 2011 Oct;129(3):887-99. doi: 10.1007/s10549-011-1520-4. Epub 2011 Apr 27.

48.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MM, Pavletic SZ.

Blood. 2011 Jun 16;117(24):6714-20. doi: 10.1182/blood-2010-12-323824. Epub 2011 Apr 14. Erratum in: Blood. 2011 Dec 22;118(26):6992.

49.

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, Pereira SE, Nash RA, Mielcarek M, Fero ML, Warren EH, Sanders JE, Storb RF, Appelbaum FR, Storer BE, Martin PJ.

Blood. 2011 Mar 17;117(11):3214-9. doi: 10.1182/blood-2010-08-302109. Epub 2011 Jan 24.

50.

HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome.

Yanover C, Petersdorf EW, Malkki M, Gooley T, Spellman S, Velardi A, Bardy P, Madrigal A, Bignon JD, Bradley P.

Immunome Res. 2011;7(2):4.

Supplemental Content

Loading ...
Support Center